Durvalumab: A Review in Limited-Stage Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Durvalumab: A Review in Limited-Stage Small Cell Lung Cancer.
Authors: France NL; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com., Syed YY; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
Source: Targeted oncology [Target Oncol] 2026 Mar; Vol. 21 (2), pp. 299-307. Date of Electronic Publication: 2026 Mar 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1776-260X
DOI:10.1007/s11523-026-01207-2